Psychology Today

Lithium: Wonder Drug or Evil Actor?

Lithium was in favor mid-century as effective in bipolar disorder (and more), then fell out due to side effects. Now, we ...
Healio

Next-generation lithium treatment for bipolar disorder to be studied

Please provide your email address to receive an email when new articles are posted on . AL001 is designed to target lithium delivery in the brain, mitigating toxicity in other organs. The drug will be ...
Psychology Today

A Return to Lithium: Psychiatry's First Miracle Drug

Lithium has long been described as the "penicillin of psychiatry" and the "gold standard" in the treatment of bipolar disorder, yet its use in the United States has decreased steadily in the past 25 ...
Business Wire

Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...
Nasdaq

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients ...

Harvard University Associate Professor, Dr. Ovidiu Andronesi MD, PhD, will be the principal investigator of the study Head-to-head study of AL001 versus a marketed lithium carbonate product will be ...
Business Wire

Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...
Seeking Alpha

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Data confirm the positive topline results announced in June 2023 identifying a maximum tolerated dose as assessed by an independent safety review committee Identified dose is unlikely to require ...